NVWM LLC’s CorMedix CRMD Stock Holding History

NVWM LLC’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-125	Closed	-$530	–	638
2024 Q1	$530	Hold	125	–	–	﹤0.01%	505
2023 Q4	$470	Sell	125 -100	-44%	-$344	﹤0.01%	384
2023 Q3	$833	Buy	+225	New	+$895	﹤0.01%	404

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NVWM LLC's CRMD Position: Q2 2024 in Review

NVWM LLC sold out of CorMedix (CRMD) in Q2 2024, closing a stake of 125 shares — an estimated $530 sold.

NVWM LLC first reported a position in CRMD in Q3 2023 and held it in 3 quarters. The position peaked at $833 in Q3 2023. 99 funds tracked by Wall St. Rank hold CRMD as of Q2 2024.

NVWM LLC reported no remaining CorMedix position as of Q2 2024 after selling out during the quarter.
NVWM LLC sold 125 CorMedix shares in Q2 2024, an estimated $530.
NVWM LLC first reported a position in CorMedix in Q3 2023 and held it in 3 quarters.
NVWM LLC's CorMedix position peaked at $833 in Q3 2023.
99 funds tracked by Wall St. Rank held CorMedix as of Q2 2024.

Based on NVWM LLC's 13F filing for Q2 2024, filed 13 Aug 2024.